A preliminary study of the effects of episil(R) oral liquid on chemotherapy- and/or radiation-induced oral mucositis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2018
At a glance
- Drugs CAM 2028 (Primary)
- Indications Mucositis
- Focus Therapeutic Use
- 01 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Dec 2017 Status changed from not yet recruiting to recruiting.
- 29 Sep 2017 New trial record